226 related articles for article (PubMed ID: 10671324)
1. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
Kuritzkes DR
Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
[TBL] [Abstract][Full Text] [Related]
2. Filgrastim treatment of HIV-infected patients improves neutrophil function.
Pitrak DL
AIDS; 1999; 13 Suppl 2():S25-30. PubMed ID: 10596678
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor: its potential role in infectious disease.
Hartung T
AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
[TBL] [Abstract][Full Text] [Related]
4. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
[TBL] [Abstract][Full Text] [Related]
5. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
Shochat E; Rom-Kedar V
Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.
Carulli G; Lazzeri E; Lagomarsini G; Zucca A; Cannizzo E; Riccioni R; Petrini M
Clin Ter; 2007; 158(3):235-7. PubMed ID: 17612284
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
Garavelli PL; Berti P
Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
[TBL] [Abstract][Full Text] [Related]
8. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of biologic response modifiers.
Louie SG; Jung B
Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S10-8. PubMed ID: 7689788
[TBL] [Abstract][Full Text] [Related]
10. Filgrastim: new indication. AIDS-associated neutropenia: another soft indication.
Prescrire Int; 2001 Aug; 10(54):106-7. PubMed ID: 11718177
[TBL] [Abstract][Full Text] [Related]
11. Cost considerations in therapy with myeloid growth factors.
Glaspy JA; Jakway J
Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bacterial infections in patients with advanced HIV infection.
Mitsuyasu R
AIDS; 1999; 13 Suppl 2():S19-23. PubMed ID: 10596677
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulins for neonatal alloimmune neutropenia refractory to recombinant human granulocyte colony-stimulating factor.
Desenfants A; Jeziorski E; Plan O; Rodière M; Rimbert M; Muller JY; Taïb J; Cambonie G
Am J Perinatol; 2011 Jun; 28(6):461-6. PubMed ID: 21136350
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
16. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
Hazar V; Ongun H; Yeşilipek MA; Yeğin O
Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
[TBL] [Abstract][Full Text] [Related]
17. Potential for immune reconstitution through G-CSF treatment of HIV patients.
Von Aulock S; Hartung T
Arch Immunol Ther Exp (Warsz); 2002; 50(2):111-20. PubMed ID: 12022700
[TBL] [Abstract][Full Text] [Related]
18. Mathematical model for G-CSF administration after chemotherapy.
Foley C; Mackey MC
J Theor Biol; 2009 Mar; 257(1):27-44. PubMed ID: 19007795
[TBL] [Abstract][Full Text] [Related]
19. Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia.
Cappozzo C
Oncol Nurs Forum; 2004 May; 31(3):569-76. PubMed ID: 15146222
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil growth factors.
Crawford J
Curr Hematol Rep; 2002 Nov; 1(2):95-102. PubMed ID: 12901130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
